Searching journal content for prostate cancer (as phrase) in full text.

Displaying results 1-10 of 712
For checked items
  1. ...prostate cancer ~~~
  2. ...prostate cancer by activating canonical Wnt/beta-catenin signaling. Cancer Letters 402 166–176. (doi:10.1016/j.canlet.2017.05.029) Lu C, Venneti S, Akalin A, Fang F, Ward PS, Dematteo RG, Intlekofer AM, Chen C, Ye J, Hameed M, et al. 2013 Induction of sarcomas by mutant IDH2. Genes and Development 2 ~~~
  3. ...prostate cancer 26 27 28 29 30 31 32 Page 2 of 40 Abstract 33 Circulating levels of prostate-specific antigen (PSA) and testosterone are 34 widely used for detection of prostate cancer prior to prostate biopsy; however 35 both remain controversial. Effective screening strategies based on 36 quantita ~~~
  4. ...prostate cancer 2 Zhu Wang 1,3,# , Dinglan Wu 4,1,# , Chi-Fai Ng , Jeremy Yuen-Chun Teoh , Shan Yu , Yuliang 3 Wang 1,* and Franky L. Chan 1,* 4 School of Biomedical Sciences and Department of Surgery, Faculty of Medicine, the 5 Chinese University of Hong Kong, Hong Kong, China 6 Department of Urolo ~~~
  5. ...prostate cancer treatment in 347 New South Wales, Australia: a validation study. BMC Health Services Res 11: 253. 348 HAGGAR, F. A., PREEN, D. B., PEREIRA, G., HOLMAN, C. D. & EINARSDOTTIR, K. 349 2012. Cancer incidence and mortality trends in Australian adolescents and young 350 adults, 1982-2007. ~~~
  6. ...prostate cancer that had progressed after 730 docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial. 731 Lancet Oncol15 700-712. 732 Larkin J, Chiarion-Sileni V, Gonzalez R, Grob JJ, Cowey CL, Lao CD, Schadendorf D, Dummer R, 733 Smylie M, Rutkowski P, et al. 201 ~~~
  7. ...prostate cancer 10.1530/ERC-17-0155 Gido Snaterse1, Jenny A Visser1, Wiebke Arlt2 and Johannes Hofland1,2 1Section of Endocrinology, Department of Internal Medicine, Erasmus MC, Rotterdam, The Netherlands 2Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK Abstrac ~~~
  8. ...prostate cancer treated with combined androgen blockade therapy. It is 14 defined by Prostate-Specific Antigen value reduction, occasionally associated with a radiological 15 response, that occurs 4 to 6 weeks after first-generation antiandrogen therapy discontinuation. 16 New-generation hormonal th ~~~
  9. ...prostate cancer tissues (Dutkiewicz et al. 1995, Sabatino  et  al. 2000, Pachucki  et  al. 2001, Wawrzynska et al. 2003). Studies performed using human PTC samples found a consistent decrease in DIO1 levels compared with the surrounding thyroid tissue, suggesting that diminished DIO1 expression migh ~~~
  10. ...prostate cancer ~~~
For checked items